Tirzepatide (Peplogix)

Product Description
Tirzepatide Research Peptide (Dual GLP-1 / GIP)
Size: Lyophilized Vial (5mg, 10mg, 30mg, 60mg)
Purity: >99% (Third-Party Tested)
Documentation: Batch-specific Certificate of Analysis (COA) available for every lot.

Product Overview
Tirzepatide is a dual GLP-1 and GIP receptor agonist and one of the most widely cited peptides in metabolic, weight-management, and endocrine research. It is used as a molecular tool in studies of insulinotropic signaling and glycemic regulation.

Every vial is manufactured under strict quality-control standards and independently verified by accredited third-party laboratories. A batch-specific Certificate of Analysis (COA) accompanies every order to confirm purity, molecular identity, and batch-to-batch consistency.

Key Features & Research Profiles
Metabolic Research Focus: A benchmark dual-receptor agonist in metabolic and weight-management research.
Rigorous Synthesis Controls: Produced under strict protocols to limit variables and support reproducible experimental data.
Accredited Verification: Full transparency with independent, third-party testing and batch-specific reporting.

Specifications & Handling
Application: For research use only. Not for human consumption.
Storage: Store at -20°C upon receipt. Protect from light and moisture. The lyophilized format maintains structural stability at room temperature for brief transit windows.